Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Switzerland

 

Synlab and Cerba looking for exits, while Unilabs in ‘no rush’

The COVID-19 pandemic has uniquely warped revenue for the big lab groups. Difficulty forecasting means Apax is in “no rush” to explore an exit while Cerba Healthcare may join Synlab in an IPO process, HBI can reveal. Synlab is reportedly on an IPO roadshow this week and Biogroup’s recent record-breaking raise on the bond market shows there’s an investor appetite. 

Ameos “prepares for sale or refinancing”

Multiple sources tell HBI that DACH psychiatry and acute hospital group Ameos is preparing for sale or refinancing. The group vehemently denies it is preparing for sale.

HBI 2020: Hospital CEOs focus on digital, the care continuum and culture 

To a remarkable extent, hospitals CEOs whether in Europe, China or Emerging Markets share the same goals around extending their patient offering forwards into primary and back into chronic and rehabilitation using digital health to achieve this. And the one thing they all know they need to get right is culture.

HBI 2020: GDPR kills off international competition for genetic tests

GDPR made it much harder to send samples outside Europe for genetic testing, the director for genetics at Europe's largest lab group Synlab told HBI 2020 delegates. He went through the basics of running a genetic lab business, including workforce, payors and the main challenges.

HBI 2020: Hospital sector is moving to outcome-based payment – insurers may get left behind

The for-profit hospital sector is moving slowly but inexorably towards value and outcome-linked reimbursement and the role for insurers within that, if there is one, is far from clear. That was the message from HBI 2020's 'Hospitals: The balance of power with payors' session where the CEOs of Mediclinic International and Steward Health Care discussed the topic with an ex-UnitedHealth Group executive.

RAD-x (finally) enters German imaging

Gilde Healthcare-backed imaging platform RAD-x has entered the German imaging sector with the acquisition of a three-centre group, HBI can reveal, and expects to close more deals in the coming months.

DACH operators should feel positive about 2021

Despite one of the panellists at HBI's DACH-State of the Regions broadcast last week labelling 2020 "the wildest year in recent history in the healthcare sector", there are lots of reasons to feel positive about Europe's German-speaking countries as we look towards the new year.

Second wave of state financial support for private hospitals

Governments across Western Europe are re-instating financial support for private hospitals involved in the second wave pandemic response. Some are treating COVID patients for the first time as hospitalisations soar above first wave numbers, but support packages are heavily-adjusted from those in spring. We talk to operators in Italy, Portugal, Germany and Switzerland and provide an update on the UK and France.

Lifting the lid on West Europe’s €60bn private non-profit hospitals

What does the non-profit hospital sector look like in West Europe and elsewhere? We are about to publish a special HBI Intelligence report, detailing market size and consolidation in eight countries, growth, potential privatisations and the expansion of US Academic Medical Centres abroad.

Find Us